Methotrexate cytotoxicity determination using the MTT assay following enzymatic depletion of thymidine and hypoxanthine
- 1 June 1993
- journal article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 119 (6) , 315-317
- https://doi.org/10.1007/bf01208836
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Chemosensitivity testing with highly purified fresh human tumour cells with the MTT colorimetric assayEuropean Journal of Cancer and Clinical Oncology, 1991
- Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemiaThe Lancet, 1991
- Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assayLeukemia Research, 1989
- Resistance to Drugs Associated With the Multidrug Resistance Phenotype Following Selection With High-Concentration MethotrexateJNCI Journal of the National Cancer Institute, 1989
- Sensitivity to Purine Analogues in Childhood Leukemia Assessed by the Automated MTT-AssayPublished by Springer Nature ,1989
- Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assayBritish Journal of Haematology, 1989
- Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemiaCancer Letters, 1988
- Use of the mtt assay for rapid determination of chemosensitivity of human leukemic blast cellsLeukemia Research, 1988
- Endogenous thymidine and hypoxanthine are a source of error in evaluating methotrexate cytotoxicity by clonogenic assays using undialyzed fetal bovine serumThe International Journal of Cell Cloning, 1986
- Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemiaCancer, 1965